Results 161 to 170 of about 3,931 (193)

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis. [PDF]

J Transl Med
Bozzini S, Bozza E, Bagnera C, Del Fante C, Barone E, De Vitis S, De Amici M, Testa G, Croce S, Valsecchi C, Avanzini MA, Cacciatore R, Mortellaro C, Viarengo G, Perotti C, Meloni F.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Extracorporeal Photopheresis

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2009
Photopheresis, originally developed in dermatology, has become a treatment method accepted across various disciplines. A basic knowledge of photomedicine and photobiology is one of the cornerstones of dermatology. Even if photopheresis is used for indications that are not specifically dermatological, e.g.
Mary Darrow, Jeanne Hendrickson, John Roback   +2 more
openaire   +3 more sources

[Extracorporeal photopheresis].

Revue medicale suisse, 2019
During the treatment of extracorporeal photopheresis (ECP), white blood cells are collected by apheresis and exposed to ultraviolet A after incubation with 8-methoxypsoralen. Although ECP was first developed for cutaneous T cell lymphoma, it has shown promising efficacy in a number of other serious conditions, like acute and chronic graft-versus-host ...
Aurélie, Hsieh, Begonia, Cortés
openaire   +3 more sources

Photopheresis (extracorporeal photochemotherapy)

Photochemical & Photobiological Sciences, 2012
Photopheresis is a form of phototherapy where specialized equipment is used to isolate a leukocyte fraction from the peripheral blood which is then exposed to photoactivated 8-methoxypsoralen and reinfused into the patient. At the time of its invention the treatment was conceptually based on the hypothesis of T cell vaccination, i.e. the observation in
Franz, Trautinger, Ulrike, Just, Robert, Knobler   +2 more
openaire   +2 more sources

Extracorporeal photopheresis: a review

Blood Reviews, 2001
Extracorporeal phototherapy (ECP) is a therapeutic approach based on the biological effect of psoralen 8-methoxypsoralen (8-MOP) and ultraviolet light A (UVA) on mononuclear cells collected by apheresis, and reinfused into the patient. Photopheresis is widely used for the treatment of patients with advanced cutaneous T-cell lymphoma (CTLC).
A, Oliven, Y, Shechter
openaire   +2 more sources

Extracorporeal Photopheresis After Heart Transplantation

Immunotherapy, 2014
The addition of extracorporeal photopheresis (ECP) to a standard immunosuppressive drug therapy after heart transplantation in clinical studies has shown to be beneficial, for example, by reducing acute rejection, allograft vasculopathy or CMV infection.
Markus J, Barten, Maja-Theresa, Dieterlen   +1 more
openaire   +2 more sources

[Extracorporeal photopheresis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995
Extracorporeal photopheresis is a new therapeutic approach developed by Edelson et al.; it is conceptually designed for the management of diseases mediated by malignant lymphocyte pathology, such as cutaneous T-cell-lymphoma (CTCL), and other disorders mediated by aberrant lymphocyte function, e.g. autoimmune diseases.
B, Prinz, G, Plewig
openaire   +1 more source

Extracorporeal photopheresis technical aspects

Transfusion and Apheresis Science, 2003
Extracorporeal photochemotherapy is a monotherapy first developed by Edelson et al. in 1987. It is a therapy in which 8-methoxypsoralen (8-MOP) containing lymphocytes are exposed to a long wavelength ultraviolet radiation (UVA) in an extracorporeal system.
openaire   +2 more sources

Extracorporeal photopheresis: Past, present, and future

Journal of the American Academy of Dermatology, 2009
Extracorporeal photopheresis (ECP) is a leukapheresis-based therapy that uses 8-methoxypsoralen and ultraviolet A irradiation. Used alone or in combination with biological agents, ECP is an established and effective therapy for advanced cutaneous T-cell lymphoma.
Knobler, R, Barr, M L, Couriel, D R, Ferrara, J L M, French, L E, Jaksch, P, Reinisch, W, Rook, A H, Schwarz, T, Greinix, H   +9 more
openaire   +2 more sources

Extracorporeal photopheresis: Clinical use so far

Journal of Clinical Apheresis, 2012
AbstractExtracorporeal photopheresis (ECP or photopheresis) is an advanced therapeutic apheresis procedure in which blood is separated into its various components and the isolated buffy coat is treated with 8‐methoxypsoralen (a photoactivating drug), exposed to ultraviolet light and returned to the patient. All other remaining blood components are also
Kimberly W, Sanford, Rasheed A, Balogun
openaire   +2 more sources